In vivo genome editing via CRISPR/Cas9 mediated homology-independent targeted integration.
Suzuki K, Tsunekawa Y, Hernandez-Benitez R, Wu J, Zhu J, Kim EJ, Hatanaka F, Yamamoto M, Araoka T, Li Z, Kurita M, Hishida T, Li M, Aizawa E, Guo S, Chen S, Goebl A, Soligalla RD, Qu J, Jiang T, Fu X, Jafari M, Esteban CR, Berggren WT, Lajara J, Nuñez-Delicado E, Guillen P, Campistol JM, Matsuzaki F, Liu GH, Magistretti P, Zhang K, Callaway EM, Zhang K, Belmonte JC.
Suzuki K, et al.
Nature. 2016 Dec 1;540(7631):144-149. doi: 10.1038/nature20565. Epub 2016 Nov 16.
Nature. 2016.
PMID: 27851729
Free PMC article.
Targeted genome editing via engineered nucleases is an exciting area of biomedical research and holds potential for clinical applications. ...The HITI method presented here establishes new avenues for basic research and targeted gene therapies....
Targeted genome editing via engineered nucleases is an exciting area of biomedical research and holds potential for clinical …